Edition:
United Kingdom

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

4.73USD
14 Dec 2017
Change (% chg)

$0.25 (+5.58%)
Prev Close
$4.48
Open
$4.30
Day's High
$4.73
Day's Low
$4.29
Volume
16,878
Avg. Vol
8,569
52-wk High
$8.56
52-wk Low
$3.58

Latest Key Developments (Source: Significant Developments)

Avenue Therapeutics reports Q3 loss per share $0.30
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Avenue Therapeutics Inc :Avenue Therapeutics Inc reports third quarter 2017 financial results and recent corporate highlights.Q3 loss per share $0.30.  Full Article

Avenue therapeutics reports Q2 loss per share $0.70
Friday, 11 Aug 2017 

Aug 11 (Reuters) - Avenue Therapeutics Inc :Avenue Therapeutics reports second quarter 2017 financial results and recent corporate highlights.Q2 loss per share $0.70.  Full Article

Avenue Therapeutics ic files for IPO of up to $50 mln
Monday, 22 May 2017 

May 22 (Reuters) - Avenue Therapeutics Inc :Avenue Therapeutics Inc files for IPO of up to $50 million - sec filing.Avenue Therapeutics Inc - expect the public offering price to be between $9.00 and $11.00 per share.Avenue Therapeutics Inc - have applied to list our common stock on the nasdaq capital market under the symbol “atxi.”.Avenue Therapeutics Inc - raymond james, national securities corporation are underwriters to the ipo.Avenue Therapeutics Inc - ipo price is estimated solely for the purpose of computing the amount of the registration fee.  Full Article

BRIEF-Avenue Therapeutics reports Q3 loss per share $0.30

* Avenue Therapeutics Inc reports third quarter 2017 financial results and recent corporate highlights

No consensus analysis data available.